Hainan Honz Pharmaceutical Co (300086) — Financial Flexibility Index
Hainan Honz Pharmaceutical Co (300086) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of CN¥-3.98 Million (operating CF CN¥-9.17 Million minus capex CN¥5.19 Million) represents 0% of total liabilities (CN¥805.18 Million). Check Hainan Honz Pharmaceutical Co (300086) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hainan Honz Pharmaceutical Co Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Hainan Honz Pharmaceutical Co across 19 annual periods. See 300086 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hainan Honz Pharmaceutical Co (2007–2025)
Year-by-year free cash flow to debt coverage for Hainan Honz Pharmaceutical Co. For the full company profile including market capitalisation, see Hainan Honz Pharmaceutical Co (300086) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥213.36 Million | CN¥121.24 Million | CN¥869.79 Million | ▲ +21.3% |
| 2024 | 0.20x | CN¥163.96 Million | CN¥71.46 Million | CN¥810.53 Million | ▼ -23.5% |
| 2023 | 0.26x | CN¥208.25 Million | CN¥70.69 Million | CN¥787.60 Million | ▲ +231.5% |
| 2022 | 0.08x | CN¥74.42 Million | CN¥29.32 Million | CN¥932.96 Million | ▼ -68.8% |
| 2021 | 0.26x | CN¥231.30 Million | CN¥11.33 Million | CN¥905.14 Million | ▼ -8.6% |
| 2020 | 0.28x | CN¥282.83 Million | CN¥-16.74 Million | CN¥1.01 Billion | ▼ -5.9% |
| 2019 | 0.30x | CN¥176.05 Million | CN¥45.06 Million | CN¥592.59 Million | ▼ -65.2% |
| 2018 | 0.85x | CN¥449.34 Million | CN¥157.66 Million | CN¥526.90 Million | ▲ +57.2% |
| 2017 | 0.54x | CN¥171.03 Million | CN¥18.17 Million | CN¥315.31 Million | ▲ +29.7% |
| 2016 | 0.42x | CN¥132.45 Million | CN¥90.88 Million | CN¥316.83 Million | ▼ -22.9% |
| 2015 | 0.54x | CN¥134.68 Million | CN¥78.30 Million | CN¥248.25 Million | ▼ -36.7% |
| 2014 | 0.86x | CN¥104.97 Million | CN¥73.93 Million | CN¥122.49 Million | ▼ -40.3% |
| 2013 | 1.44x | CN¥135.48 Million | CN¥78.93 Million | CN¥94.36 Million | ▼ -14.9% |
| 2012 | 1.69x | CN¥160.27 Million | CN¥109.46 Million | CN¥95.02 Million | ▲ +1016.7% |
| 2011 | -0.18x | CN¥-20.38 Million | CN¥-100.94 Million | CN¥110.77 Million | ▼ -107.2% |
| 2010 | 2.56x | CN¥194.79 Million | CN¥79.89 Million | CN¥76.01 Million | ▼ -11.6% |
| 2009 | 2.90x | CN¥155.43 Million | CN¥93.58 Million | CN¥53.60 Million | ▲ +67.7% |
| 2008 | 1.73x | CN¥96.71 Million | CN¥62.61 Million | CN¥55.93 Million | ▼ -12.8% |
| 2007 | 1.98x | CN¥50.92 Million | CN¥30.59 Million | CN¥25.68 Million | — |